Tirzepatide is a dual-action metabolic medication used for type 2 diabetes and weight loss. It mimics two natural gut hormones at the same time, which makes it more powerful than older single-hormone drugs. Tirzepatide activates:
GLP-1 receptor
- Reduces appetite and food cravings
- Slows stomach emptying
- Improves blood sugar control
GIP receptor
- Enhances insulin release
- Improves insulin sensitivity
- Helps regulate fat metabolism
- May reduce nausea compared with GLP-1 alone
Main effects in the body
- Strong appetite suppression
- Significant weight loss
- Lower blood sugar and A1C
- Improved insulin sensitivity
- Reduced liver fat
- Better cardiometabolic markers
Approved uses
- Type 2 diabetes (Mounjaro®)
- Chronic weight management (Zepbound®)
Disclaimer: This is for research and informational purposes only. For medical advice or diagnosis, consult a professional.
